Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
42
SPNS Quote, Financials, Valuation and Earnings
Last price:
$27.76
Seasonality move
:
3.88%
Day range:
$27.13 - $28.21
52-week range:
$26.34 - $41.22
Dividend yield:
2.05%
P/E ratio:
21.86x
P/S ratio:
2.89x
P/B ratio:
3.31x
Volume:
220.2K
Avg. volume:
224K
1-year change:
-2.01%
Market cap:
$1.6B
Revenue:
$514.6M
EPS (TTM):
$1.27
Analysts' Opinion
-
Consensus RatingSapiens International Corp NV has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Sapiens International Corp NV has an estimated upside of 14.37% from its current price of $27.76.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $27.76.
Fair Value
-
According to the consensus of 0 analysts, Sapiens International Corp NV has 14.37% upside to fair value with a price target of -- per share.
SPNS vs. S&P 500
-
Over the past 5 trading days, Sapiens International Corp NV has underperformed the S&P 500 by -0.55% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sapiens International Corp NV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sapiens International Corp NV has grown year-over-year revenues for 24 quarters straight. In the most recent quarter Sapiens International Corp NV reported revenues of $137M.
Earnings Growth
-
Sapiens International Corp NV has grown year-over-year earnings for 7 quarters straight. In the most recent quarter Sapiens International Corp NV reported earnings per share of $0.33.
Enterprise value:
1.4B
EV / Invested capital:
2.76x
Price / LTM sales:
2.89x
EV / EBIT:
16.68x
EV / Revenue:
2.61x
PEG ratio (5yr expected):
1.10x
EV / Free cash flow:
20.33x
Price / Operating cash flow:
22.53x
Enterprise value / EBITDA:
13.34x
Gross Profit (TTM):
$233.9M
Return On Assets:
10.56%
Net Income Margin (TTM):
13.23%
Return On Equity:
15.88%
Return On Invested Capital:
14.42%
Operating Margin:
15.87%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $474.5M | $503.2M | $538.9M | $130.7M | $137M | |
| Gross Profit | $198.5M | $214M | $233.9M | $56M | $60.3M | |
| Operating Income | $65.7M | $75.3M | $84.2M | $20.3M | $21.7M | |
| EBITDA | $93M | $97.1M | $105.3M | $25.3M | $26.8M | |
| Diluted EPS | $0.95 | $1.06 | $1.27 | $0.28 | $0.33 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $205.9M | $275.4M | $269.1M | $290.4M | $321.4M | |
| Total Assets | $550.1M | $699.9M | $642.2M | $650.2M | $683.3M | |
| Current Liabilities | $128.6M | $151.4M | $143.3M | $139.6M | $147.3M | |
| Total Liabilities | $297.2M | $309.1M | $265M | $230.4M | $212M | |
| Total Equity | $252.9M | $390.8M | $377.2M | $419.7M | $471.3M | |
| Total Debt | $118.5M | $98.8M | $79M | $59.3M | $39.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $56.7M | $55.2M | $78.8M | $4M | $13.1M | |
| Cash From Investing | $6M | -$64.3M | $18.2M | $12.3M | $21.3M | |
| Cash From Financing | -$57.4M | -$43.2M | -$53.7M | -$9.6M | -$14.2M | |
| Free Cash Flow | $46.3M | $46.1M | $69.1M | $1.6M | $10.1M | |
SPNS
Sector
Market Cap
$1.6B
$115.4M
Price % of 52-Week High
67.35%
67.8%
Dividend Yield
2.05%
0%
Shareholder Yield
--
1%
1-Year Price Total Return
-2.01%
-6.36%
Beta (5-Year)
1.151
0.944
Dividend yield:
2.05%
Annualized payout:
$0.51
Payout ratio:
41.79%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$28.28
200-day SMA
Sell
Level
$33.63
Bollinger Bands (100)
Sell
Level
29.96 - 37.72
Chaikin Money Flow
Buy
Level
11.4M
20-day SMA
Sell
Level
$27.97
Relative Strength Index (RSI14)
Sell
Level
37.25
ADX Line
Sell
Level
9.29
Williams %R
Neutral
Level
-74.6988
50-day SMA
Sell
Level
$31.85
MACD (12, 26)
Sell
Level
-0.87
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
37.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.6931)
Buy
CA Score
(Annual)
Level (0.9267)
Buy
Beneish M-Score
(Annual)
Level (-2.5545)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.4555)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
Stock Forecast FAQ
In the current month, SPNS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SPNS average analyst price target in the past 3 months is --.
-
Where Will Sapiens International Corp NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sapiens International Corp NV share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Sapiens International Corp NV?
Analysts are divided on their view about Sapiens International Corp NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sapiens International Corp NV is a Sell and believe this share price will drop from its current level to --.
-
What Is Sapiens International Corp NV's Price Target?
The price target for Sapiens International Corp NV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SPNS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sapiens International Corp NV is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SPNS?
You can purchase shares of Sapiens International Corp NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sapiens International Corp NV shares.
-
What Is The Sapiens International Corp NV Share Price Today?
Sapiens International Corp NV was last trading at $27.76 per share. This represents the most recent stock quote for Sapiens International Corp NV. Yesterday, Sapiens International Corp NV closed at $27.76 per share.
-
How To Buy Sapiens International Corp NV Stock Online?
In order to purchase Sapiens International Corp NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
